Skip to main content
. 2016 Jun 15;193(12):1353–1363. doi: 10.1164/rccm.201506-1223OC

Table 5.

Results for Published Candidate Genes in the Variant Segregation Analysis and Case–Control Association Analysis

Gene Source EOCOPD (No. of Pedigrees) SNP Location COPDGene P Value Effect
CCDC38 Lung function 1 12-96272113 0.0457 Protective
DNER Lung function 1 2-230231749 0.6453 Deleterious
EGLN2 COPD 1 19-41307024 0.9071 Protective
FAM13A COPD 1 4-89950680 0.6424 Deleterious
GPR126 Lung function 1 6-142723802 0.9141 Deleterious
MECOM Lung function 1 3-169099162 0.0588 Protective
NMBR Lung function 1 6-142409506 0.7902 Deleterious
KCNJ2 Lung function 1 17-68171232
CYP2A6 COPD 0 0.0021 Protective
RHOBTB3 Lung function 0 0.0382 Protective
THSD4 Lung function 0 0.0330 Protective
ZNF323 Lung function 0 0.0347 Protective

Definition of abbreviations: COPD = chronic obstructive pulmonary disease; EOCOPD = Early-Onset Chronic Obstructive Pulmonary Disease Study; SNP = single-nucleotide polymorphism.

Genes that are segregating in at least one EOCOPD pedigree or have a P value less than 0.05 using the T5 test in the COPDGene dataset are listed here. No. of Pedigrees indicates the number of pedigrees with a segregating variant. COPDGene P value refers to the result from the T5 test.